Literature DB >> 27344317

Cirrhotic patients have good insight into their daily functional impairment despite prior hepatic encephalopathy: comparison with PROMIS norms.

Jasmohan S Bajaj1, Melanie B White2, Ariel B Unser2, Dinesh Ganapathy2, Andrew Fagan2, Edith A Gavis2, Richard K Sterling2, Douglas M Heuman2, Scott Matherly2, Puneet Puri2, Arun J Sanyal2, Velimir Luketic2, Michael Fuchs2, Muhammad S Siddiqui2, R Todd Stravitz2, Binu John2, Leroy R Thacker3, James B Wade4.   

Abstract

Health-related quality of life (HRQOL) is an important determinant of prognosis in cirrhosis and hepatic encephalopathy (HE). However due to inherent cognitive dysfunction, insight into HRQOL severity in patients with liver disease may be impaired. To assess insight into HRQOL using PROMIS tools compared to norms in cirrhotic patients. PROMIS tools are validated HRQOL instruments that test the domains of anger, anxiety, depression, physical function, pain behavior/impact, sleep disturbances/impairment, and social activities/roles, compared to US-norms. Patients were administered the PROMIS tools, the results of which were reviewed using a visual comparison with thed norms. Then two Likert scales from 0 to 10 per domain were administered that inquired about (1) Surprise Intensity: 0-4: not surprised, 5-10: surprised; and (2) Expectancies: 0-4: results better than expected, 5:10: as/worse than expected. Comparisons between HE/no-HE were also performed. 203 cirrhotic patients (57 yrs., 62 % men, MELD 12, 83 HE) were included. All HE patients were controlled on therapy. Prior HE patients were significantly impaired on all PROMIS domains (p < 0.01) except anger, compared to the re st. The majority (76-85 %) were not surprised with their placement vis-à-vis the norms. Similarly, a majority (59-61 %) thought their results were worse or as expected. However, a third of patients found that their PROMIS results were better than expected. Prior HE status did not significantly impact expectations or surprise based on placement with the norms. The majority of cirrhotic patients, regardless of prior HE, have good insight regarding their HRQOL issues.

Entities:  

Keywords:  Cognition; Health-related quality of life; PROMIS; Sleep

Mesh:

Year:  2016        PMID: 27344317      PMCID: PMC5033693          DOI: 10.1007/s11011-016-9860-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  14 in total

1.  Catastrophizing, depression and expectancies for pain and emotional distress.

Authors:  M J Sullivan; W M Rodgers; I Kirsch
Journal:  Pain       Date:  2001-03       Impact factor: 6.961

2.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

3.  Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel.

Authors:  Honghu Liu; David Cella; Richard Gershon; Jie Shen; Leo S Morales; William Riley; Ron D Hays
Journal:  J Clin Epidemiol       Date:  2010-08-05       Impact factor: 6.437

4.  PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis.

Authors:  J S Bajaj; L R Thacker; J B Wade; A J Sanyal; D M Heuman; R K Sterling; D P Gibson; R T Stravitz; P Puri; M Fuchs; V Luketic; N Noble; M White; D Bell; D A Revicki
Journal:  Aliment Pharmacol Ther       Date:  2011-09-19       Impact factor: 8.171

5.  The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers.

Authors:  Jasmohan S Bajaj; James B Wade; Douglas P Gibson; Douglas M Heuman; Leroy R Thacker; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Michael Fuchs; Melanie B White; Debulon E Bell; HoChong Gilles; Katherine Morton; Nicole Noble; Puneet Puri; Arun J Sanyal
Journal:  Am J Gastroenterol       Date:  2011-05-10       Impact factor: 10.864

6.  Driving simulation can improve insight into impaired driving skills in cirrhosis.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Douglas M Heuman; Douglas P Gibson; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Arun J Sanyal; James B Wade
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

7.  Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.

Authors:  Oliviero Riggio; Lorenzo Ridola; Chiara Pasquale; Silvia Nardelli; Ilaria Pentassuglio; Federica Moscucci; Manuela Merli
Journal:  Clin Gastroenterol Hepatol       Date:  2010-10-15       Impact factor: 11.382

8.  Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.

Authors:  Sridharan Umapathy; Radha K Dhiman; Sandeep Grover; Ajay Duseja; Yogesh K Chawla
Journal:  Am J Gastroenterol       Date:  2014-04-29       Impact factor: 10.864

9.  Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study.

Authors:  Sanath Allampati; Andres Duarte-Rojo; Leroy R Thacker; Kavish R Patidar; Melanie B White; Jagpal S Klair; Binu John; Douglas M Heuman; James B Wade; Christopher Flud; Robert O'Shea; Edith A Gavis; Ariel B Unser; Jasmohan S Bajaj
Journal:  Am J Gastroenterol       Date:  2015-12-08       Impact factor: 10.864

10.  Health-related quality of life predicts mortality in patients with advanced chronic liver disease.

Authors:  Fasiha Kanwal; Ian M Gralnek; Ron D Hays; Angelique Zeringue; Francisco Durazo; Steven B Han; Sammy Saab; Roger Bolus; Brennan M R Spiegel
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-21       Impact factor: 11.382

View more
  4 in total

1.  Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis.

Authors:  Kavish R Patidar; Leroy R Thacker; James B Wade; Melanie B White; Edith A Gavis; Andrew Fagan; Richard K Sterling; Michael Fuchs; Mohammad S Siddiqui; Scott Matherly; Richard T Stravitz; Arun J Sanyal; Puneet Puri; Velimir A Luketic; Jasmohan S Bajaj
Journal:  Dig Dis Sci       Date:  2017-03-03       Impact factor: 3.199

2.  Liver transplant candidates have impaired quality of life across health domains as assessed by computerized testing.

Authors:  Jonathan G Stine; George J Stukenborg; Jennifer Wang; Alden Adkins; Blake Niccum; Alex Zimmet; Curtis K Argo
Journal:  Ann Hepatol       Date:  2019-09-11       Impact factor: 2.400

Review 3.  Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues.

Authors:  Sara Montagnese; Jasmohan S Bajaj
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

4.  Ammonia-induced mitochondrial impairment is intensified by manganese co-exposure: relevance to the management of subclinical hepatic encephalopathy and cirrhosis-associated brain injury.

Authors:  Reza Heidari; Akram Jamshidzadeh; Mohammad Mehdi Ommati; Elaheh Rashidi; Forouzan Khodaei; Ala Sadeghi; Arghavan Hosseini; Hossein Niknahad
Journal:  Clin Exp Hepatol       Date:  2019-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.